Importantly, the metabolic consequences of GLP-1RA therapy arise not only from appetite suppression but also from sustained GLP-1R signaling under conditions of chronically reduced nutrient inflow
In addition to genetic predispositions, variability in TC and TG concentration results from physical activity, diet, including carbohydrate and alcohol content, and smoking
However, early research, as well as our understanding of how other medications get into milk, are promising that some of these medications may be compatible with lactation
Some unofficially call Alzheimers disease type 3 diabetes, for example, because issues with insulin signaling are tied to the accumulation of peptides characteristic of Alzheimers
Impact of GLP-1 Drug Adoption on Consumer Food Demand GLP-1 weight loss drugs are likely to impact long-term category growth rates for food consumption
Newer medications are exploring combinations of hormone-based injectables, like glucagon-like peptide-1 agonists, with other agents to improve results and reduce side effects